Genetic polymorphism of sparteine/debrisoquine oxidation: a reappraisal (Q37782957)

23 August 2017

1 reference

title

Genetic polymorphism of sparteine/debrisoquine oxidation: a reappraisal (English)

1 reference

23 August 2017

Lennard MS

1 reference

23 August 2017

publication date

1 October 1990

1 reference

Basic and Clinical Pharmacology and Toxicology

23 August 2017

published in

1 reference

23 August 2017

1 reference

23 August 2017

1 reference

23 August 2017

page(s)

273-283

1 reference

Inter-ethnic and inter-phenotype differences among Ghanaians and Caucasians in the metabolic hydroxylation of phenytoin [proceedings]

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1990.TB00830.X

Variable metabolism of pinacidil: lack of correlation with the debrisoquine and trimethylamine C- and N-oxidative polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1990.TB00830.X

The contribution of genetically determined oxidation status to inter-individual variation in phenacetin disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1990.TB00830.X

The effects of diabetes mellitus, exercise, and single doses of biguanides upon lactate metabolism in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1990.TB00830.X

Discovery of altered pharmacokinetics of CGP 15 210 G in poor hydroxylators of debrisoquine during early drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1990.TB00830.X

Metoprolol and debrisoquin metabolism in Nigerians: lack of evidence for polymorphic oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1990.TB00830.X

Polymorphic drug oxidation: pharmacokinetic basis and comparison of experimental indices

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1990.TB00830.X

Testing for bimodality in frequency distributions of data suggesting polymorphisms of drug metabolism--histograms and probit plots

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1990.TB00830.X

Testing for bimodality in frequency distributions of data suggesting polymorphisms of drug metabolism--hypothesis testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1990.TB00830.X

Inhibition of metoprolol metabolism by chloroquine and other antimalarial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1990.TB00830.X

Debrisoquine metabolism and genetic predisposition to lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1990.TB00830.X

Metoprolol metabolism and debrisoquine oxidation polymorphism--population and family studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1990.TB00830.X

Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1990.TB00830.X

Dextromethorphan: polymorphic serum pattern of the O-demethylated and didemethylated metabolites in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1990.TB00830.X

Genetic polymorphism of phenformin 4-hydroxylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1990.TB00830.X

Debrisoquine oxidation in an Australian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1990.TB00830.X

The disposition of debrisoquine in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1990.TB00830.X

Genetically determined oxidation capacity and the disposition of debrisoquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1990.TB00830.X

Quinidine and the identification of drugs whose elimination is impaired in subjects classified as poor metabolizers of debrisoquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1990.TB00830.X

A family study of genetic and environmental factors determining polymorphic hydroxylation of debrisoquin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1990.TB00830.X

Codeine O-demethylation co-segregates with polymorphic debrisoquine hydroxylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1990.TB00830.X

In vitro characterization of the human cytochrome P-450 involved in polymorphic oxidation of propafenone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1990.TB00830.X

The influence of the sparteine/debrisoquin phenotype on the disposition of flecainide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1990.TB00830.X

10.1111/J.1600-0773.1990.TB00830.X

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference